ð ãåã«æ°Žã¶ãããã§ããããäœã«åž¯ç¶ã®çºç¹ãåºããââãããªçµéšããããŸãããïŒ
ãåžè²©è¬ã§å€§äžå€«ïŒãããšãç é¢ãžïŒã
æŸçœ®ãããã©ããªãâŠïŒ
ãã®èšäºãèªãã°ããã«ãã¹ã®çš®é¡ã»çç¶ã»æ£ããå¯ŸåŠæ³ããŸãããšããããŸãã
èªãŸãªããŸãŸæŸçœ®ãããšãåçºãªã¹ã¯ãä»äººãžã®æææ¡å€§ã«ã€ãªããããšãã
ç®æ¬¡
- ð ãã«ãã¹ãŠã€ã«ã¹ãšã¯ã©ããªãŠã€ã«ã¹ã
- ð ãã«ãã¹ãŠã€ã«ã¹ã®çš®é¡ãšç¹åŸŽ
- ð åçŽãã«ãã¹ãŠã€ã«ã¹ïŒHSV-1ã»HSV-2ïŒã®çç¶ãšææçµè·¯
- ð æ°Žçã»åž¯ç¶ç±ç¹ãŠã€ã«ã¹ïŒVZVïŒã«ã€ããŠ
- ð EBãŠã€ã«ã¹ïŒEB virusïŒãšãµã€ãã¡ã¬ããŠã€ã«ã¹ïŒCMVïŒ
- ð ãã«ãã¹ãŠã€ã«ã¹ãåæŽ»æ§åããä»çµã¿
- ð ãã«ãã¹ãŠã€ã«ã¹ã®èšºææ¹æ³
- ð ãã«ãã¹ãŠã€ã«ã¹ã®æ²»çæ³
- ð æ¥åžžçæŽ»ã§ã®äºé²çãšæææ¡å€§ãé²ãããã®æ³šæç¹
- ð ãŸãšã
ð¡ ãã®èšäºã®ãã€ã³ã
â
ãã«ãã¹ãŠã€ã«ã¹ã¯8çš®é¡ååšããäžåºŠææãããšäœå
ã«æœäŒãå
ç«äœäžæã«å掻æ§åããã
â
æãŠã€ã«ã¹è¬ã®æ©æäœ¿çšãšåž¯ç¶ç±ç¹ã¯ã¯ãã³çã«ããäºé²ãæå¹ã
â
æ°ã«ãªãçç¶ã¯æ©ãã«å»çæ©é¢ãå蚺ããããšãéèŠã
ð¡ 1. ãã«ãã¹ãŠã€ã«ã¹ãšã¯ã©ããªãŠã€ã«ã¹ã
ãã«ãã¹ãŠã€ã«ã¹ã¯ããã«ãã¹ãŠã€ã«ã¹ç§ïŒHerpesviridaeïŒã«å±ãããŠã€ã«ã¹ã®ç·ç§°ã§ãããŠã€ã«ã¹ãšããŠã®å€§ããªç¹åŸŽã¯ãäžåºŠææãããšäœå ïŒç¥çµç¯ïŒã«æœäŒãç¶ããå ç«ãäœäžãããšããªã©ã«åã³æŽ»æ§åãããšããç¹ã«ãããŸãã
ãã«ãã¹ãŠã€ã«ã¹ã®ç²åã¯ãšã³ãããŒãïŒè質æ§ã®èïŒã«å ãŸããŠãããçŽåŸã¯150ã200ããã¡ãŒãã«çšåºŠã®æ¯èŒç倧åã®ãŠã€ã«ã¹ã§ããéºäŒæ å ±ã¯DNAã«èšé²ãããŠãããããã¯ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãæ°åã³ãããŠã€ã«ã¹ãRNAãŠã€ã«ã¹ã§ããã®ãšã¯ç°ãªããŸããDNAãŠã€ã«ã¹ã§ããããšã¯ãæãŠã€ã«ã¹è¬ã®èšèšã«ã圱é¿ããŠãããæ žé žã¢ããã°ç³»ã®è¬ãæ²»çã«æå¹ãªçç±ã®ã²ãšã€ã«ããªã£ãŠããŸãã
人éã«ææãããã«ãã¹ãŠã€ã«ã¹ã¯çŸåš8çš®é¡ã確èªãããŠããããããããç°ãªãçŸæ£ãåŒãèµ·ãããŸããããã«ãã¹ããšããèšèã¯å£åãã«ãã¹ãæ§åšãã«ãã¹ã®ã€ã¡ãŒãžã匷ãã§ããã垯ç¶ç±ç¹ãäŒææ§åæ žççãçªçºæ§çºç¹ãªã©ãåºãæå³ã§ãã«ãã¹ãŠã€ã«ã¹ã«ããææçã«å«ãŸããŸãã
ãã«ãã¹ãŠã€ã«ã¹ã¯äžçäžã«åºãååžããŠãããç¹å®ã®å°åãç°å¢ã«éãããææçã§ã¯ãããŸãããæ¥æ¬ã«ãããŠãææçã¯éåžžã«é«ããåçŽãã«ãã¹ãŠã€ã«ã¹1åïŒHSV-1ïŒã«ã€ããŠã¯æäººã®50ã80%以äžãæäœãæã€ãšãããŠããŸããå€ãã®å Žåãåææã¯å¹Œå°æã«èµ·ãããç¡çç¶ã軜çã§çµããããšãå€ããããèªåããã§ã«ææããŠããããšã«æ°ã¥ããŠããªãæ¹ãå€ãããŸãã
Q. ãã«ãã¹ãŠã€ã«ã¹ãšã¯ã©ã®ãããªç¹åŸŽãæã€ãŠã€ã«ã¹ã§ããïŒ
ãã«ãã¹ãŠã€ã«ã¹ã¯ããã«ãã¹ãŠã€ã«ã¹ç§ã«å±ããDNAãŠã€ã«ã¹ã®ç·ç§°ã§ã人éã«ææãããã®ã¯8çš®é¡ç¢ºèªãããŠããŸããæå€§ã®ç¹åŸŽã¯ãäžåºŠææãããšç¥çµç¯ãªã©ã«æœäŒãç¶ããå ç«æ©èœãäœäžããéã«å掻æ§åããç¹ã§ããå£åãã«ãã¹ã»åž¯ç¶ç±ç¹ã»æ°Žçãªã©ãå«ãŸããŸãã
ð 2. ãã«ãã¹ãŠã€ã«ã¹ã®çš®é¡ãšç¹åŸŽ
人éã«ææãããã«ãã¹ãŠã€ã«ã¹ã¯ã以äžã®8çš®é¡ã«åé¡ãããŸããããããã®ç¹åŸŽãæŽçããããšã§ãèªåã«é¢ä¿ã®ããææçãææ¡ãããããªããŸãã
ãŸãããããã«ãã¹ãŠã€ã«ã¹1åïŒHHV-1ïŒã¯åçŽãã«ãã¹ãŠã€ã«ã¹1åïŒHSV-1ïŒãšãåŒã°ããäž»ã«å£åãé¡é¢ã«çç¶ãåŒãèµ·ãããŸããæ¬¡ã«ããããã«ãã¹ãŠã€ã«ã¹2åïŒHHV-2ïŒã¯åçŽãã«ãã¹ãŠã€ã«ã¹2åïŒHSV-2ïŒã§ãäž»ã«æ§åšãã«ãã¹ã®åå ãšãªããŸãããã ããè¿å¹Žã§ã¯æ§è¡çºã®ã¹ã¿ã€ã«ã®å€åã«ãããHSV-1ãå£è ããæ§åšã«ææããã±ãŒã¹ãå¢ããŠãããããåãšææéšäœã®å¯Ÿå¿é¢ä¿ã¯å¿ ãããåºå®ãããã®ã§ã¯ãããŸããã
ãããã«ãã¹ãŠã€ã«ã¹3åïŒHHV-3ïŒã¯æ°Žçã»åž¯ç¶ç±ç¹ãŠã€ã«ã¹ïŒVZVïŒãšããŠç¥ãããåã©ãã®ãšãã«æ°ŽçïŒæ°ŽãŒãããïŒãåŒãèµ·ãããæäººä»¥éã«åž¯ç¶ç±ç¹ãšããŠå掻æ§åããããšããããŸãããããã«ãã¹ãŠã€ã«ã¹4åïŒHHV-4ïŒã¯EBãŠã€ã«ã¹ïŒEpstein-BarrãŠã€ã«ã¹ïŒã§ãäŒææ§åæ žççã®åå ãšããŠæåã§ãããŸããäžåœé ãããäžéšã®ãªã³ãè «ãšã®é¢é£ãå ±åãããŠããŸãã
ãããã«ãã¹ãŠã€ã«ã¹5åïŒHHV-5ïŒã¯ãµã€ãã¡ã¬ããŠã€ã«ã¹ïŒCMVïŒã§ãå¥åžžãªæäººã§ã¯çç¶ãåºã«ãããã®ã®ãå ç«äžå šç¶æ ãåŠåš äžã®åææã§ã¯é節ãªåé¡ãåŒãèµ·ããããšããããŸãããããã«ãã¹ãŠã€ã«ã¹6åïŒHHV-6ïŒããã³7åïŒHHV-7ïŒã¯ã乳幌å ã®çªçºæ§çºç¹ã®åå ãšããŠç¥ãããŠããŸãããããŠããããã«ãã¹ãŠã€ã«ã¹8åïŒHHV-8ïŒã¯ã«ããžèè «ã«é¢é£ãããŠã€ã«ã¹ãšããŠç¥ãããŠãããäž»ã«å ç«ãèããäœäžããHIVææè ãªã©ã§åé¡ãšãªããŸãã
ãããã®ãŠã€ã«ã¹ã¯ãã¹ãŠãææåŸã«äœå ã®ããéšäœã«æœäŒããå ç«æ©èœã®äœäžãªã©ããã£ãããšããŠåã³æŽ»åãå§ãããšããå ±éããæ§è³ªãæã£ãŠããŸããæœäŒããå Žæã¯ãŠã€ã«ã¹ã®çš®é¡ã«ãã£ãŠç°ãªããåçŽãã«ãã¹ãŠã€ã«ã¹ã¯ç¥çµç¯ãEBãŠã€ã«ã¹ããµã€ãã¡ã¬ããŠã€ã«ã¹ã¯ãªã³ãçãªã©ããã®å ŽæãšãªããŸãã
âš 3. åçŽãã«ãã¹ãŠã€ã«ã¹ïŒHSV-1ã»HSV-2ïŒã®çç¶ãšææçµè·¯
æ¥åžžçæŽ»ã§æãããç®ã«ãããã«ãã¹ãŠã€ã«ã¹ææçã®ã²ãšã€ããåçŽãã«ãã¹ãŠã€ã«ã¹ã«ãããã®ã§ããå£åãã«ãã¹ãšæ§åšãã«ãã¹ã«åããŠèª¬æããŸãã
â å£åãã«ãã¹ïŒHSV-1ãäž»ãªåå ïŒ
å£åãã«ãã¹ã¯ãåãå£ã®åšå²ã«ããã¿ã»ããªããªãšããéåæãçããããšããå§ãŸãããã®åŸã«å°ããªæ°Žã¶ããïŒæ°Žç±ïŒãéãŸã£ãŠçŸããŸããæ°Žç±ã¯æ°æ¥ã§ã€ã¶ããããã¶ããšãªã£ãŠæ²»çã«åãããŸããçºçããæ²»çãŸã§ããããã1ã2é±éçšåºŠããããŸãã
åæææã¯å£å çïŒãã«ãã¹æ§æ¯èå£å çïŒãšããŠçŸããããšãå€ããçºç±ã»åŠæ æã»ãªã³ãç¯è «è¹ãªã©ã®å šèº«çç¶ã䌎ãããšããããŸããç¹ã«ä¹³å¹Œå ã§ã¯éçåããããããæ³šæãå¿ èŠã§ãã
ææçµè·¯ã¯ãäž»ã«æ¥è§ŠææïŒãŠã€ã«ã¹ãå«ãŸããåŸæ¶²ãç®èã®åæ³ç©ãšã®çŽæ¥æ¥è§ŠïŒã§ãããã¹ãé£åšã®å ±çšãã¿ãªã«ã®å ±çšãªã©ã«ãã£ãŠææãåºããããšããããŸãããŸããçç¶ãåºãŠããªãæœäŒæã«ããŠã€ã«ã¹ãæåºãããããšãããïŒäžé¡æ§æåºïŒãããçç¶ã®ãªããšãã«ãä»è ãžææãããå¯èœæ§ãããããšãçè§£ããŠããå¿ èŠããããŸãã
ð æ§åšãã«ãã¹ïŒHSV-2ã»HSV-1ïŒ
æ§åšãã«ãã¹ã¯ãæ§åšã»èéåšå²ã»èéšãªã©ã«æ°Žç±ã朰çãçããææçã§ããåæææã¯çºç±ãåŠæ æãéŒ åŸéšãªã³ãç¯è «è¹ãªã©ã®å šèº«çç¶ã䌎ããçã¿ã匷ããªãããšããããŸãã女æ§ã§ã¯æå°¿çã䌎ãããšããããŸãã
åçºæ§æ§åšãã«ãã¹ã§ã¯ãåææããçç¶ã軜ããªãããšãå€ããæ°Žç±ãåºãåãã屿ã®éåæïŒããã¿ã»ããªããªæïŒãçŸããåé§çç¶ãçµéšããæ¹ãããŸãããã ããåçºé »åºŠã«ã¯å人差ãããã幎ã«äœåºŠãç¹°ãè¿ãæ¹ãããã°ãã»ãšãã©åçºããªãæ¹ãããŸãã
ææçµè·¯ã¯æ§çæ¥è§Šãäž»ã§ããããªãŒã©ã«ã»ãã¯ã¹ã«ãã£ãŠHSV-1ãæ§åšã«ææããã±ãŒã¹ãå¢ããŠããŸãããŸããçç¶ããªãææã§ããŠã€ã«ã¹ã®æåºãèµ·ããåŸããããææãªã¹ã¯ããŒãã«ããããšã¯é£ããã®ãçŸå®ã§ããã³ã³ããŒã ã®äœ¿çšã¯ãªã¹ã¯ãäœæžããŸãããå®å šã«ã¯é²ããªããšãããŠããŸãã
æ§åšãã«ãã¹ã¯æ§ææçïŒSTIïŒã®ã²ãšã€ãšããŠäœçœ®ã¥ããããŠãããããŒãããŒãžã®ææãªã¹ã¯ãèæ ®ãã察å¿ãæ±ããããŸãããŸããåŠåš äžã®åææãååš©æã®æŽ»åæ§ææã¯æ°çå ãã«ãã¹ã®åå ãšãªããããåŠå©Šããã¯ç£ç§å»ãžã®çžè«ãç¹ã«éèŠã§ãã
Q. 垯ç¶ç±ç¹ã¯ã©ã®ãããªä»çµã¿ã§çºçããŸããïŒ
垯ç¶ç±ç¹ã¯ãå¹Œå°æã«æ°ŽçïŒæ°ŽãŒãããïŒãšããŠææããæ°Žçã»åž¯ç¶ç±ç¹ãŠã€ã«ã¹ãèé«åŸæ ¹ç¥çµç¯ã«æœäŒãç¶ããå 霢ã»éåŽã»ã¹ãã¬ã¹ãªã©ã§å ç«ãäœäžããããšã奿©ã«å掻æ§åããŠçºçããŸããäœã®å·Šå³ã©ã¡ããã«åž¯ç¶ã®ç®ç¹ãšçã¿ãçŸããçæ¶¯çºç確çã¯çŽ3人ã«1人ãšãããŠããŸãã
ð 4. æ°Žçã»åž¯ç¶ç±ç¹ãŠã€ã«ã¹ïŒVZVïŒã«ã€ããŠ
æ°Žçã»åž¯ç¶ç±ç¹ãŠã€ã«ã¹ïŒVaricella-Zoster VirusïŒVZVïŒã¯ããã«ãã¹ãŠã€ã«ã¹ã®äžã§ãå€ãã®æ¹ãé¢ããå¯èœæ§ã®ãããŠã€ã«ã¹ã§ããåææã§ã¯æ°ŽçïŒæ°ŽãŒãããïŒãåŒãèµ·ãããæ²»çåŸã¯èé«åŸæ ¹ç¥çµç¯ãªã©ã«æœäŒãç¶ããŸãã
ðž æ°ŽçïŒæ°ŽãŒãããïŒ
æ°Žçã¯å šèº«ã«èµ€ãçºç¹ã»æ°Žç±ã次ã ãšçŸãã匷ãããã¿ãäŒŽãææçã§ããææåãéåžžã«åŒ·ããç©ºæ°ææïŒé£æ²«æ žææïŒã»é£æ²«ææã»æ¥è§Šææã®ãããã§ãåºãããŸããåŠæ ¡ãä¿è²åãªã©ã§é壿æãèµ·ããããçç±ãããã«ãããŸãã
åã©ãã®ãã¡ã¯ã»ãšãã©ã®å Žåã軜çã§æ²»çããŸãããæäººãåææããå Žåããå ç«äžå šç¶æ ã«ããæ¹ã»æ°çå ã§ã¯éçåãããªã¹ã¯ããããŸããçŸåšã¯æ°Žçã¯ã¯ãã³ã宿æ¥çš®ïŒ2014幎ããïŒãšãªã£ãŠãããäºé²æ¥çš®ã«ãã£ãŠææãé²ãããšãæšå¥šãããŠããŸãã
⡠垯ç¶ç±ç¹
垯ç¶ç±ç¹ã¯ãå¹Œå°æã«æ°ŽçãšããŠåææããVZVãç¥çµç¯ã«æœäŒããå ç«ã®äœäžããã£ããã«å掻æ§åããããšã§çºçããŸããäœã®å·Šå³ã©ã¡ããã®ç¥çµã®èµ°è¡ã«æ²¿ã£ãŠã垯ç¶ã«ç®ç¹ãåºãã®ãç¹åŸŽã§ããèžã»è ¹ã»èäžã»é¡ã»è ã»è¶³ãªã©ãäœã®ã©ã®éšäœã«ãçºçããå¯èœæ§ããããŸãã
垯ç¶ç±ç¹ã®åæçç¶ã¯ç®ç¹ãåºãåããå§ãŸãããšãå€ããçºç¹ãåºãæ°æ¥åããæ£éšã«ããªããªãšããçã¿ãããã¿ãçããŸããçºç¹ãåºãŠæ°Žç±ãç Žããããã¶ãã«ãªã£ãŠæ²»çãããŸã§ã«2ã4é±éçšåºŠããããŸãã
垯ç¶ç±ç¹ã§æãåé¡ãšãªãå䜵çã®ã²ãšã€ãã垯ç¶ç±ç¹åŸç¥çµçïŒPHNïŒPost-herpetic NeuralgiaïŒã§ããç®ç¹ãæ²»çããåŸãã3ã¶æä»¥äžã«ããã£ãŠåŒ·ãçã¿ãç¶ãç¶æ ã§ãé«éœ¢è ã»ã©çºçãªã¹ã¯ãé«ããšãããŠããŸããçã¿ã¯æ¥åžžç掻ã«å€§ããæ¯éããããããšããããçæŽ»ã®è³ªïŒQOLïŒãèããäœäžãããããšããããŸãã
垯ç¶ç±ç¹ã¯50代以éã®çºçãå€ããçæ¶¯ã«äžåºŠã¯çºçãã確çã¯çŽ3人ã«1人ãšãããããŠããŸããçŸåšã¯åž¯ç¶ç±ç¹ã¯ã¯ãã³ãå©çšå¯èœã§ãããç¹ã«é«éœ¢ã®æ¹ãžã®ã¯ã¯ãã³æ¥çš®ãæšå¥šãããŠããŸããã¯ã¯ãã³ã«ã¯çã¯ã¯ãã³ïŒä¹Ÿç¥åŒ±æ¯çæ°Žçã¯ã¯ãã³ïŒãšäžæŽ»åã¯ã¯ãã³ïŒã·ã³ã°ãªãã¯ã¹ïŒã®2çš®é¡ããããããããç¹åŸŽãç°ãªããŸãã
ðª 5. EBãŠã€ã«ã¹ïŒEB virusïŒãšãµã€ãã¡ã¬ããŠã€ã«ã¹ïŒCMVïŒ
EBãŠã€ã«ã¹ïŒEpstein-BarrãŠã€ã«ã¹ïŒãšãµã€ãã¡ã¬ããŠã€ã«ã¹ïŒCMVïŒã¯ãäžè¬çãªç¥å床ããäœããã®ã®ãææçãé«ããç¹å®ã®ç¶æ³äžã§ã¯æ·±å»ãªåé¡ãåŒãèµ·ãããã«ãã¹ãŠã€ã«ã¹ã§ãã
ð EBãŠã€ã«ã¹ïŒHHV-4ïŒ
EBãŠã€ã«ã¹ã¯äžçäžã§åºãååžããŠãããæäººã®90%以äžãææããŠãããšãããŸããå¹Œå°æã®åææã¯å€ãã®å Žåç¡çç¶ã軜çã§ããã10代åŸåã20代ã§åææããå Žåã«ã¯ãäŒææ§åæ žççïŒinfectious mononucleosisïŒãçºçããããšããããŸãã
äŒææ§åæ žççã®äž»ãªçç¶ã¯ãçºç±ã»ã®ã©ã®çã¿ïŒææ¡çïŒã»é žéšãªã³ãç¯è «è¹ã»åŠæ æã»èèŸè «ïŒèèã»èŸèã®è «å€§ïŒãªã©ã§ããããã¹ç ïŒkissing diseaseïŒããšãåŒã°ããããã«ãåŸæ¶²ãä»ããææïŒãã¹ãé£åšã®å ±çšãªã©ïŒãäž»ãªææçµè·¯ã§ãã
EBãŠã€ã«ã¹ãäœå ã«æœäŒããåŸãBãªã³ãçã«é·æéã«ããã£ãŠæœäŒãç¶ããŸããå ç«äžå šç¶æ ã§ã¯å掻æ§åãèµ·ããããšãããããŸããæ ¢æ§æŽ»åæ§EBãŠã€ã«ã¹ææçïŒCAEBVïŒããäžåœé ããã»ããŒããããªã³ãè «ã»ããžãã³ãªã³ãè «ãªã©ã®äžéšã®æªæ§è «çãšã®é¢é£ãç ç©¶ã«ãã£ãŠç€ºãããŠããŸãããã ããEBãŠã€ã«ã¹ã«ææããã ãã§ããã«ãªãããã§ã¯ãªããçºçã«ã¯è€æ°ã®èŠå ãé¢äžããŠãããšèããããŠããŸãã
ð¬ ãµã€ãã¡ã¬ããŠã€ã«ã¹ïŒHHV-5ïŒ
ãµã€ãã¡ã¬ããŠã€ã«ã¹ïŒCMVïŒãéåžžã«ææçã®é«ããŠã€ã«ã¹ã§ãæäººã§ã¯60ã90%ãææããŠãããšãããŸããå¥åžžãªå ç«æ©èœãæã€æäººã§ã¯ãææããŠãç¡çç¶ã軜ã颚éªã®ãããªçç¶ã§çµããããšãã»ãšãã©ã§ãã
ããããèåšç§»æ€åŸã®å ç«æå¶çæ³äžã®æ£è ããããHIVææã«ãã£ãŠå ç«æ©èœãèããäœäžããæ£è ããã§ã¯ãCMVç¶²èçã»CMVèºçã»CMVè žçãªã©ã®é節ãªçŸæ£ãåŒãèµ·ããããšããããŸãããã®ãããªå ç«äžå šç¶æ ã§ã¯CMVã®ç®¡çãéèŠãªå»ç課é¡ã®ã²ãšã€ãšãªã£ãŠããŸãã
ãŸããåŠåš äžã®åææã¯å 倩æ§ãµã€ãã¡ã¬ããŠã€ã«ã¹ææçã®åå ãšãªãåŸãŸããèå ã«ææããå Žåãé£èŽã»èŠåé害ã»ç¥çé害ã»å°é çãªã©ããããããšããããå å€©æ§ææçã®äžã§ã¯æ¯èŒçé »åºŠãé«ãããæ³šæãå¿ èŠã§ããåŠå©Šããã¯åŠåš äžã«åææãããªã¹ã¯ãäžããããã«ãææŽãã培åºãã幌å ã®åŸæ¶²ã»å°¿ãšã®æ¥è§Šã«æ³šæããããšãæšå¥šãããŠããŸãã
Q. ãã«ãã¹ææçã®æãŠã€ã«ã¹è¬ã¯ãã€é£²ã¿å§ããã¹ãã§ããïŒ
å£åãã«ãã¹ã»æ§åšãã«ãã¹ã»åž¯ç¶ç±ç¹ãããããçºçãã48ã72æé以å ã«æãŠã€ã«ã¹è¬ïŒã¢ã·ã¯ããã«ã»ãã©ã·ã¯ããã«ãªã©ïŒãéå§ããããšãéèŠã§ããæ©ææçšã«ããçç¶ã®æç¶æéã®ççž®ãéçåã®é²æ¢ãæåŸ ã§ããŸãããæ§åãèŠããããšå€æãå éãã«ãããæ©ãã«å»çæ©é¢ãå蚺ããããšãæšå¥šãããŸãã
ð¯ 6. ãã«ãã¹ãŠã€ã«ã¹ãåæŽ»æ§åããä»çµã¿
ãã«ãã¹ãŠã€ã«ã¹ã®å€§ããªç¹åŸŽã®ã²ãšã€ããåææåŸã«äœå ã§æœäŒãç¶ããäœããã®ãã£ããã§å掻æ§åãããšããæ§è³ªã§ãããã®ä»çµã¿ãçè§£ããããšã¯ãåçºäºé²ãèããããã§éåžžã«éèŠã§ãã
åçŽãã«ãã¹ãŠã€ã«ã¹ãäŸã«åããšãåææåŸã«äžåç¥çµç¯ïŒé¡é¢ã»å£è ïŒãä»éªšç¥çµç¯ïŒæ§åšåšå²ïŒã«æœäŒããŸããæœäŒç¶æ ã§ã¯å ç«ç³»ã«ããæé€ãéããŠããããŠã€ã«ã¹ã¯èªèº«ã®è€è£œãæå°éã«æããŠã鿢ãããŠããŸãã
åæŽ»æ§åãåŒãèµ·ããèŠå ãšããŠãå ç«æ©èœã®äœäžãæãéèŠã§ããå ·äœçã«ã¯ä»¥äžã®ãããªç¶æ³ãåŒãéã«ãªãããšãç¥ãããŠããŸãããŸããéåŽã»ç¡ç äžè¶³ã»ã¹ãã¬ã¹ãªã©ã«ããäœã®ç²åŒãæããããŸããæ¬¡ã«ãçºç±ã»é¢šéªãªã©ã®ä»ã®ææçã«ããå ç«æ¶èãèŠå ãšãªããŸãããŸãã玫å€ç·ïŒæ¥å ãžã®é·æéæé²ïŒã«ãã屿ã®å ç«äœäžãã¹ããã€ãè¬ãå ç«æå¶å€ãªã©ã®è¬ç©äœ¿çšãæçµååŸã®ãã«ã¢ã³ãã©ã³ã¹ã®å€åãå€å·ã»æè¡ãªã©ã®äœãžã®ç©ççã¹ãã¬ã¹ãåæŽ»æ§åã®èŠå ãšããŠå ±åãããŠããŸãã
åæŽ»æ§åãèµ·ãããšããŠã€ã«ã¹ãç¥çµãäŒã£ãŠç®èãç²èã«å°éããçç¶ãåŒãèµ·ãããŸããåæŽ»æ§åã®éã®çç¶ã¯åææãšæ¯ã¹ãŠè»œãããšãå€ãã§ãããäœã®ç¶æ ã«ãã£ãŠã¯éçåããããšããããŸããç¹ã«é«éœ¢è ãå ç«äžå šã®æ¹ã§ã¯ã垯ç¶ç±ç¹ã®éçåãããã«ãã¹è³çãªã©ã®å䜵çã«æ³šæãå¿ èŠã§ãã
ãŸããåæŽ»æ§åã«ã¯çç¶ã䌎ããªããäžé¡æ§å掻æ§åããããããã®éãä»è ãžã®ãŠã€ã«ã¹äŒæãèµ·ããåŸãŸãããããæææ¡å€§ã®äžå ãšãªããããææé²æ¢ã®èгç¹ããéåžžã«éèŠãªæŠå¿µã§ãã
ð¡ 7. ãã«ãã¹ãŠã€ã«ã¹ã®èšºææ¹æ³
ãã«ãã¹ãŠã€ã«ã¹ææçã®èšºæã¯ãçç¶ã»èŠèšºã«ãã確èªãšãå¿ èŠã«å¿ããŠè¡ãæ€æ»ã«ãã£ãŠè¡ãããŸãã
â èŠèšºã»å蚺ã«ãã蚺æ
å£åãã«ãã¹ã垯ç¶ç±ç¹ã¯ãç¹åŸŽçãªç®ç¹ã®åœ¢ç¶ã»éšäœã»ååžãã¿ãŒã³ãããçç·Žããå»åž«ã§ããã°èŠèšºã ãã§èšºæã§ããããšãå€ããããŸãããã ããçç¶ãéå žåçãªå Žåããå ç«äžå šæ£è ã§çç¶ãè€éãªå Žåã«ã¯ã远å ã®æ€æ»ãå¿ èŠã«ãªããŸãã
ð ãŠã€ã«ã¹åŠçæ€æ»
PCRæ€æ»ïŒããªã¡ã©ãŒãŒé£éåå¿æ³ïŒã¯ãç å€éšã®æãæ¶²ã»æ°Žç±æ¶²ã»è³è髿¶²ãªã©ã®ãµã³ãã«ãããŠã€ã«ã¹ã®DNAãæ€åºããæ¹æ³ã§ããæåºŠã»ç¹ç°åºŠãšãã«é«ããçŸåšæãä¿¡é Œæ§ã®é«ãèšºææ¹æ³ãšãããŠããŸããç¹ã«ãã«ãã¹è³çãæ°çå ãã«ãã¹ãçãããå Žåã«ã¯ãè³è髿¶²ã®PCRæ€æ»ãè¡ãããŸãã
ãŠã€ã«ã¹åé¢å¹é€ã確å®ãªæ¹æ³ã§ãããçµæãåºããŸã§æéãããããããç·æ¥æ§ã®ããå Žåã«ã¯åããŠããŸããã
ðž è¡æž åŠçæ€æ»ïŒæäœæ€æ»ïŒ
è¡æ¶²æ€æ»ã«ãã£ãŠãã«ãã¹ãŠã€ã«ã¹ã«å¯ŸããæäœïŒIgGã»IgMïŒã枬å®ããããšã§ãéå»ã®æææŽãçŸåšé²è¡äžã®ææã調ã¹ãããšãã§ããŸãããã ããåæææã«ã¯IgMæäœã®åºçŸã«æéããããããšããŸãæ¢ææè ãšå掻æ§åã®åºå¥ãé£ããã±ãŒã¹ãããããšãããåç¬ã§ç¢ºå®èšºæã«çšããããšã¯é£ãããšãããŠããŸããæ§åšãã«ãã¹ã®åã®ç¢ºèªïŒHSV-1ãHSV-2ãïŒã調ã¹ãéã«ã¯ãåç¹ç°çæäœæ€æ»ãçšããããããšããããŸãã
â¡ ãã®ä»ã®æ€æ»
ãã¡ã³ã¯è©ŠéšïŒTzanck smearïŒã¯ãæ°Žç±ã®åºåºéšã®çްèãæ¡åããŠã®ã ã¶æè²ãããŠã€ã«ã¹ææã«ç¹åŸŽçãªå€æ žå·šçްèã確èªããæ¹æ³ã§ããæè»œã«å®æœã§ããŸããæåºŠã»ç¹ç°åºŠã¯PCRããäœãããããŸã§è£å©çãªæ€æ»ãšããŠçšããããŸãã
çŒçç¶ã䌎ãå ŽåïŒãã«ãã¹è§èçã»ãã«ãã¹çŒéšåž¯ç¶ç±ç¹ãªã©ïŒã¯çŒç§ã§ã®ç²Ÿå¯æ€æ»ãç¥çµçç¶ã䌎ãå Žåã«ã¯ç¥çµå ç§ãšã®é£æºã®ããšãMRIãè³è髿¶²æ€æ»ãªã©ãè¡ãããŸãã
Q. 垯ç¶ç±ç¹ã¯ã¯ãã³ã®çš®é¡ãšå¯Ÿè±¡å¹Žéœ¢ãæããŠãã ãã
æ¥æ¬ã§ã¯50æ³ä»¥äžã察象ã«2çš®é¡ã®åž¯ç¶ç±ç¹ã¯ã¯ãã³ãå©çšå¯èœã§ããçã¯ã¯ãã³ïŒãã±ã³ïŒã¯1åæ¥çš®ãäžæŽ»åã¯ã¯ãã³ïŒã·ã³ã°ãªãã¯ã¹ïŒã¯2ã¶æééã§2åæ¥çš®ãå¿ èŠã§ããã·ã³ã°ãªãã¯ã¹ã¯äºé²å¹æãçŽ97%ãšé«ãäžæ¹ãæ¥çš®åŸã«åŠæ æãè ã®çã¿ãåºãããç¹åŸŽããããŸããããããä»»ææ¥çš®ã§ãäžéšèªæ²»äœã§ã¯è£å©å¶åºŠããããŸãã
ð 8. ãã«ãã¹ãŠã€ã«ã¹ã®æ²»çæ³
ãã«ãã¹ãŠã€ã«ã¹ææçã«ã¯ãçŸåšããã€ãã®æãŠã€ã«ã¹è¬ãååšããŠããŸãããããã¯å®å šã«ãŠã€ã«ã¹ãäœå ããæé€ãããã®ã§ã¯ãããŸããããçç¶ãççž®ãããããéçåãé²ãã ããåçºã®é »åºŠãæžãã广ããããŸãã
ð æãŠã€ã«ã¹è¬ã®çš®é¡
åçŽãã«ãã¹ãŠã€ã«ã¹ããã³æ°Žçã»åž¯ç¶ç±ç¹ãŠã€ã«ã¹ã®æ²»çã«çšããããäž»ãªè¬ã¯ãæ žé žã¢ããã°ç³»ã®æãŠã€ã«ã¹è¬ã§ãã代衚çãªãã®ãšããŠãã¢ã·ã¯ããã«ïŒacyclovirïŒããã©ã·ã¯ããã«ïŒvalacyclovirïŒããã¡ã ã·ã¯ããã«ïŒfamciclovirïŒããããŸãã
ã¢ã·ã¯ããã«ã¯æãæŽå²ããããå£å çã»å£åãã«ãã¹ã»æ§åšãã«ãã¹ã»åž¯ç¶ç±ç¹ã»æ°Žçã»ãã«ãã¹è³çãªã©å¹ åºãé©å¿ãæã¡ãŸãããã©ã·ã¯ããã«ã¯ã¢ã·ã¯ããã«ã®ãããã©ãã°ã§ãäœå ã§ã¢ã·ã¯ããã«ã«å€æãããã¢ã·ã¯ããã«ããæè¬åæ°ãå°ãªãæžãããå©äŸ¿æ§ãé«ããšãããŠããŸãããã¡ã ã·ã¯ããã«ã¯åž¯ç¶ç±ç¹ãæ§åšãã«ãã¹ã«çšããããŸãã
ãããã®è¬å€ã®äœçšæ©åºã¯ããŠã€ã«ã¹ã现èå ã§è€è£œããéã«å¿ èŠãªé µçŽ ïŒãããžã³ãããŒãŒãDNAããªã¡ã©ãŒãŒïŒãé»å®³ããããšã§ããããã®çްèã«ååšããé µçŽ ãšã®éžææ§ãé«ããããéåžžã®çšéã§ã¯å¯äœçšãåºã«ãããšãããŠããŸãã
EBãŠã€ã«ã¹ããµã€ãã¡ã¬ããŠã€ã«ã¹ã«å¯ŸããŠã¯ãã¢ã·ã¯ããã«ç³»ã®è¬ã®å¹æãéå®çãªããšããããã¬ã³ã·ã¯ããã«ïŒganciclovirïŒããã¹ã«ã«ãããïŒfoscarnetïŒãªã©ãçšããããããšããããŸãããããã¯å ç«äžå šæ£è ã§ã®éçCMVææçã®æ²»çã«äœ¿ãããŸãã
ð¬ æ¥æ§æã®æ²»ç
å£åãã«ãã¹ãæ§åšãã«ãã¹ã®æ¥æ§æã«ã¯ãçç¶ãåºãæ©ã段éããæãŠã€ã«ã¹è¬ãéå§ããããšãéèŠã§ããçºçãã48ã72æé以å ã«å æãå§ããããšã§ãçç¶ã®æç¶æéãççž®ãã广ãæåŸ ã§ããŸãã軜çã®å£åãã«ãã¹ã§ã¯ãã¢ã·ã¯ããã«ãªã©ãå«ãæãŠã€ã«ã¹è¬ã®å€çšè¬ïŒã¯ãªãŒã ã»è»èïŒãåŠæ¹ãããããšããããŸãããã ããå€çšè¬ã¯å æè¬ãšæ¯ã¹ãŠå¹æãéå®çã§ãããšããå ±åããããŸãã
垯ç¶ç±ç¹ã®æ¥æ§ææ²»çã§ããçºç¹åºçŸåŸã§ããã ãæ©ãïŒéåžž72æé以å ïŒæãŠã€ã«ã¹è¬ã®å æãéå§ããããšããçç¶ã®è»œæžãšåž¯ç¶ç±ç¹åŸç¥çµçã®äºé²ã«æå¹ãšãããŠããŸããé«éœ¢è ãå ç«äžå šè ãçŒéšã»è³éšã»é¡é¢ã«çºçããéçäŸã§ã¯ãç¹æ»Žã«ããæ²»çïŒã¢ã·ã¯ããã«ã®éèå æäžïŒãè¡ãããããšããããŸãã
â åçºæå¶çæ³

æ§åšãã«ãã¹ãªã©ã幎ã«äœåºŠãåçºãç¹°ãè¿ãæ¹ã«å¯ŸããŠã¯ãåçºæå¶çæ³ïŒsuppressive therapyïŒãéžæãããããšããããŸããããã¯ãæãŠã€ã«ã¹è¬ãæ¯æ¥ç¶ç¶çã«å æããããšã§åçºã®é »åºŠãæžããããã€ããŒãããŒãžã®ãŠã€ã«ã¹äŒæãªã¹ã¯ãäœäžãããæ²»çæ³ã§ãã
éåžžã幎ã«6å以äžåçºããæ¹ã«é©å¿ãæ€èšãããããšãå€ããæ²»çæéã¯æ£è ããã®ç¶æ³ã«å¿ããŠå»åž«ã倿ããŸããé·æéã®æçšã«é¢ããå®å šæ§ã¯ç¢ºèªãããŠããŸãããè¬ã«èæ§ã®ãããŠã€ã«ã¹ãåºçŸãããªã¹ã¯ããŒãã§ã¯ãªãããã宿çãªå蚺ãšè©äŸ¡ãå¿ èŠã§ãã
ð çã¿ã®ã³ã³ãããŒã«
垯ç¶ç±ç¹ã«äŒŽãç¥çµçã¯ãæãŠã€ã«ã¹è¬ã ãã§ã¯ååã«ã³ã³ãããŒã«ã§ããªãå ŽåããããŸããæ¥æ§æã«ã¯éã¹ããã€ãæ§æççè¬ïŒNSAIDsïŒãã¢ã»ãã¢ãããã§ã³ãå Žåã«ãã£ãŠã¯ãªããªã€ãç³»é®çè¬ã䜿ãããããšããããŸãã垯ç¶ç±ç¹åŸç¥çµçã«ã¯ããã¬ã¬ããªã³ã»ã¬ããã³ãã³ïŒç¥çµé害æ§çŒçæ²»çè¬ïŒãäžç°ç³»æãã€è¬ãå±æéº»é è¬ããããªã©ãçšããããŸãããã€ã³ã¯ãªããã¯ïŒçŒç倿¥ïŒã§ã®ç¥çµãããã¯çæ³ãæå¹ãªå ŽåããããŸãã
âš 9. æ¥åžžç掻ã§ã®äºé²çãšæææ¡å€§ãé²ãããã®æ³šæç¹
ãã«ãã¹ãŠã€ã«ã¹ãäœå ããå®å šã«æé€ããããšã¯çŸæç¹ã§ã¯é£ãããããããã«çºçãæããä»è ãžã®ææãé²ãããéèŠã«ãªããŸãã
ðž å ç«åãç¶æããçæŽ»ç¿æ £
ãã«ãã¹ãŠã€ã«ã¹ã®å掻æ§åãé²ãã«ã¯ãå ç«æ©èœãæ£åžžã«ä¿ã€ããšãåºæ¬ã§ããååãªç¡ç ããšãããšããã©ã³ã¹ã®åããé£äºããšãããšãé床ãªã¹ãã¬ã¹ããããªãããšã倧åã§ããæ¿ããéåã«ããé床ã®ç²åŽãå ç«æ©èœãäžæçã«äœäžãããããšããããããé©åºŠãªéåãç¶ç¶ããããšãæãŸãããšãããŠããŸãã
å£åãã«ãã¹ãç¹°ãè¿ãæ¹ã¯ã玫å€ç·ãåŒãéã«ãªãããšãå€ããããå€åºæã®æ¥çŒãæ¢ãããªããã¯ãªãŒã ã®äœ¿çšïŒæ¥çŒãæ¢ãæåå ¥ãã®ãã®ãæå¹ïŒãæçšã§ãã
â¡ ä»è ãžã®ææãé²ãããã®è¡å
å£åãã«ãã¹ã掻åæïŒæ°Žç±ãåºãŠããææïŒã«ã¯ãæ£éšãžã®æ¥è§Šãé¿ããã®ã¯ãã¡ãããé£åšã»ã°ã©ã¹ã»ã¿ãªã«ãªã©ã®å ±çšãé¿ããæ¥å»ïŒãã¹ïŒãæ§ããŸããããæ°Žç±ãå®å šã«ããã¶ãã«ãªã£ãŠæ²»çãããŸã§ã¯ææåããããšãããŠããŸãã
å ç«åã®äœãæ°çå ã乳幌å ãžã®å£åãã«ãã¹ã®ææã¯æ·±å»ãªçµæã«ã€ãªããããšããããããæŽ»åæã«ã¯èµ€ã¡ãããžã®ãã¹ãé¡ãžã®æ¥è§Šãå³çŠã«ããããšãæ±ããããŸãããŸããåãçç±ãããã¢ãããŒæ§ç®èçã®ããåã©ããžã®ãã«ãã¹ãŠã€ã«ã¹ã®ææãã«ããžæ°Žçæ§çºç¹çãšããé節ãªç¶æ ãåŒãèµ·ããããšãããããæ³šæãå¿ èŠã§ãã
æ§åšãã«ãã¹ã«ã€ããŠã¯ã掻åæã¯ãã¡ãããç¡çç¶ã®ææã§ãäžé¡æ§æåºã«ãã£ãŠææãèµ·ããåŸãŸããã³ã³ããŒã ã®äœ¿çšã¯ãªã¹ã¯ãäžããæå¹ãªææ®µã§ãããå®å šã§ã¯ãªãããšãããŒãããŒãšå ±æãããäºãã®ç¶æ³ã«ã€ããŠãªãŒãã³ã«è©±ãåãããšãéèŠã§ãã
ð ã¯ã¯ãã³ã«ããäºé²
ãã«ãã¹ãŠã€ã«ã¹ææçã«å¯Ÿããã¯ã¯ãã³ãšããŠãçŸå𿥿¬ã§å©çšå¯èœãªãã®ãæŽçããŸãã
æ°Žçã¯ã¯ãã³ã¯2014幎ãã宿æ¥çš®ãšãªã£ãŠããã1æ³ãš3æ³åïŒ1æ³ã®1åç®ãã3ã¶æä»¥äžãããŠ2åç®ïŒã®2åæ¥çš®ãæšå¥šãããŠããŸããæ°Žçã®äºé²ãšåæã«ãå°æ¥ã®åž¯ç¶ç±ç¹çºçãªã¹ã¯ãæžããããšã«ãã€ãªãããšèããããŠããŸãã
垯ç¶ç±ç¹ã¯ã¯ãã³ã«ã¯2çš®é¡ããããŸãã也ç¥åŒ±æ¯çæ°Žçã¯ã¯ãã³ïŒãã±ã³ïŒã¯50æ³ä»¥äžã察象ã§ã1åæ¥çš®ã§ããäžæŽ»åã¯ã¯ãã³ïŒã·ã³ã°ãªãã¯ã¹ïŒã¯50æ³ä»¥äžã察象ã§ã2ã¶æééã§2åæ¥çš®ãå¿ èŠã§ããã·ã³ã°ãªãã¯ã¹ã¯åž¯ç¶ç±ç¹äºé²å¹æãçŽ97%ãšé«ãã垯ç¶ç±ç¹åŸç¥çµçã®äºé²ã«ãåªããŠãããšãããŠããŸãããæ¥çš®è²»çšãåå¿ã®åŒ·ãïŒæ¥çš®åŸã®åŠæ æã»è ã®çã¿ãªã©ïŒã«ã€ããŠå»åž«ãšçžè«ã®ããéžæããããšãæãŸããã§ããããããä»»ææ¥çš®ïŒèªå·±è² æ ïŒãšãªã£ãŠããŸãããäžéšã®èªæ²»äœã§ã¯è£å©ãåºãå ŽåããããŸãã
ð¬ å蚺ã®ã¿ã€ãã³ã°
以äžã®ãããªçç¶ãç¶æ³ãããå Žåã¯ãæ©ãã«å»çæ©é¢ãå蚺ããããšããå§ãããŸããçºç¹ãé¡ã»ç®ã®åšå²ã«åºãŠããå Žåã¯ãç¹ã«çŒéšåž¯ç¶ç±ç¹ãçãããå Žåã«æ©æ¥ãªå¯Ÿå¿ãå¿ èŠã§ããé«ç±ã»é çã»æèã®å€åãªã©ã®å šèº«çç¶ã䌎ãå Žåãå ç«æ©èœãäœäžããŠããæ¹ïŒã¹ããã€ã䜿çšäžã»HIVææã»èåšç§»æ€åŸãªã©ïŒã«ãã«ãã¹çç¶ãåºãå ŽåãåŠåš äžã«åææãçãããå Žåãåæ§ã§ãããŸããåçºãç¹°ãè¿ããŠæ¥åžžçæŽ»ã«æ¯éãããããŠããå Žåãçžè«ãå¿ èŠã§ãã
ãã«ãã¹ãŠã€ã«ã¹ææçã¯ãæ©æã«é©åãªæ²»çãéå§ããããšã§çç¶ã®è»œæžãå䜵çã®äºé²ã«ã€ãªãããŸãããããããã«ãã¹ããšæãããæ°ã«ãªãçç¶ãããã°ç®èç§ã»æ³å°¿åšç§ã»å©Šäººç§ã»å ç§ãªã©ãçç¶ã«å¿ãã蚺çç§ãžã®åèšºãæ€èšããŠãã ããã
ðšââïž åœé¢ã§ã®èšºçåŸåãå»åž«ã³ã¡ã³ãã
髿¡åº·å€ª å»åž«ïŒåœé¢æ²»ç責任è ïŒãã
ãåœé¢ã§ã¯ããåã«æ°Žã¶ãããã§ããããäœã®çåŽã ãã«çºç¹ãšçã¿ãããããšãã£ããçžè«ãå€ãããã ããŸãããæŸçœ®ãããŠããå蚺ãããæ¹ãå°ãªããªããæ©æå蚺ã®å€§åããæ¹ããŠæããŠããŸãããã«ãã¹ãŠã€ã«ã¹ã¯äžåºŠææãããšäœå ã«æœäŒãç¶ããããå®å šã«æé€ããããšã¯ã§ããŸããããçç¶ãåºãéã«æ©æããæãŠã€ã«ã¹è¬ãéå§ããããšã§çç¶ã®è»œæžãå䜵çã®äºé²ã«ã€ãªãããŸãã®ã§ããããããããšã¯ãªãã ããããšå€æãå éãã«ãããæ°ã«ãªãçç¶ãããã°ãæ©ãã«ãçžè«ãã ãããç¹ã«åž¯ç¶ç±ç¹ã¯é«éœ¢ã«ãªãã»ã©éçåãªã¹ã¯ã垯ç¶ç±ç¹åŸç¥çµçã®ãªã¹ã¯ãé«ãŸããŸãã®ã§ãäºé²ã¯ã¯ãã³ã®æŽ»çšãå«ããŠãæ£è ãããäžäººãã²ãšãã®ç¶æ³ã«åãããäžå¯§ãªãææ¡ãå¿ãããŠãããŸããã
ð ãããã質å
å€ãã®å Žåãåææã¯ç¡çç¶ã軜çã§çµãããããèªèŠããªããŸãŸææããŠããæ¹ãå€ãããŸããå£åãæ§åšåšå²ã®æ°Žã¶ãããäœã®çåŽã«åž¯ç¶ã«åºãçºç¹ãªã©ã代衚çãªãµã€ã³ã§ããæ°ã«ãªãçç¶ãããå Žåã¯ãèŠèšºãè¡æ¶²æ€æ»ã»PCRæ€æ»ãªã©ã§èšºæã§ããŸãã®ã§ãåœé¢ãžãæ°è»œã«ãçžè«ãã ããã
ã¯ãããã€ãå¯èœæ§ããããŸãããã«ãã¹ãŠã€ã«ã¹ã¯çç¶ãåºãŠããªãææã«ããŠã€ã«ã¹ãæåºããããäžé¡æ§æåºããèµ·ããããšããããŸããç¹ã«æ§åšãã«ãã¹ã§ã¯ç¡çç¶æã®ææãªã¹ã¯ãç¥ãããŠããŸããã³ã³ããŒã ã®äœ¿çšã§ãªã¹ã¯ã¯äžããããŸããå®å šã§ã¯ãªããããããŒãããŒãšã®ååãªè©±ãåããéèŠã§ãã
å¹Œå°æã«æ°ŽçïŒæ°ŽãŒãããïŒã«ææããããšãããæ¹ã§ããã°ã誰ã§ãçºçããå¯èœæ§ããããŸããç¹ã«50代以éã®é«éœ¢è ãéåŽã»ã¹ãã¬ã¹ãç¶ããŠããæ¹ãå ç«æå¶å€ã䜿çšäžã®æ¹ã¯ãªã¹ã¯ãé«ããšãããŠããŸããçæ¶¯çºç確çã¯çŽ3人ã«1人ãšãããããŠãããåœé¢ã§ã¯äºé²ã¯ã¯ãã³ã®ãçžè«ãæ¿ã£ãŠããŸãã
ã¯ããã§ããã ãæ©ãæè¬éå§ãéèŠã§ããå£åãã«ãã¹ãæ§åšãã«ãã¹ã垯ç¶ç±ç¹ãããããçºçãã48ã72æé以å ã«æãŠã€ã«ã¹è¬ãéå§ããããšã§ãçç¶ã®æéççž®ãéçå鲿¢ã®å¹æãæåŸ ã§ããŸãããæ§åãèŠããããšå€æãå éãã«ãããæ°ã«ãªãçç¶ãçŸãããæ©ãã«å»çæ©é¢ãå蚺ããããšããå§ãããŸãã
æ¥æ¬ã§ã¯50æ³ä»¥äžã®æ¹ã察象ã§ããã¯ã¯ãã³ã«ã¯2çš®é¡ãããçã¯ã¯ãã³ïŒãã±ã³ïŒã¯1åæ¥çš®ãäžæŽ»åã¯ã¯ãã³ïŒã·ã³ã°ãªãã¯ã¹ïŒã¯2ã¶æééã§2åæ¥çš®ãå¿ èŠã§ããã·ã³ã°ãªãã¯ã¹ã¯äºé²å¹æãçŽ97%ãšé«ãäžæ¹ãæ¥çš®åŸã«åŠæ æãè ã®çã¿ãåºãããç¹åŸŽããããŸããã©ã¡ããé©ããŠãããã¯åœé¢ã«ãŠãçžè«ããã ããŸãã
ðª ãŸãšã
ãã«ãã¹ãŠã€ã«ã¹ã¯ç§ãã¡ã®ç掻ã«éåžžã«èº«è¿ãªãŠã€ã«ã¹ã®ç·ç§°ã§ãããå£åãã«ãã¹ã»æ§åšãã«ãã¹ã»åž¯ç¶ç±ç¹ã»æ°Žçã»äŒææ§åæ žççãªã©ãããŸããŸãªææçã®åå ãšãªããŸãã
æãéèŠãªç¹åŸŽã¯ãäžåºŠææãããšäœå ã«æœäŒãç¶ããå ç«æ©èœã®äœäžãªã©ã奿©ã«å掻æ§åãããšããç¹ã§ãããã®æ§è³ªãããçæ¶¯ã«ããã£ãŠä»ãåãç¶ããææçã§ãããšããããŸãã
çŸåšã¯æå¹ãªæãŠã€ã«ã¹è¬ãååšããŠãããæ©æã«æ²»çãéå§ããããšã§çç¶ã軜æžããå䜵çãé²ãããšãå¯èœã§ãããŸããæ°Žçã¯ã¯ãã³ã垯ç¶ç±ç¹ã¯ã¯ãã³ã«ããäºé²ãéžæè¢ã®ã²ãšã€ãšãªã£ãŠããŸãã
æ¥åžžç掻ã§ã¯ãå ç«æ©èœãç¶æããèŠåæ£ããçæŽ»ç¿æ £ãå¿ãããããšã掻åæã«ã¯ä»è ãžã®ææé²æ¢çã培åºããããšããããŠæ°ã«ãªãçç¶ãããã°æ©ãã«å蚺ããããšã倧åã§ãã
ã¢ã€ã·ãŒã¯ãªããã¯å€§å®®é¢ã§ã¯ããã«ãã¹ãŠã€ã«ã¹ææçã«é¢ãããçžè«ã«ãäžå¯§ã«å¯Ÿå¿ããŠãããŸããããããããŠâŠããšæãããããšãããã°ãã©ãããæ°è»œã«ãæ¥é¢ãã ãããé©åãªèšºæãšæ²»çã®ãææ¡ãããããŸãã
ð é¢é£èšäº
- ã€ãã«æ¶²äœçªçŽ æ²»çã¯å¹æçïŒä»çµã¿ã»åæ°ã»çã¿ã詳ãã解説
- é¡ã®ãããããããããããªãïŒåå ãšæ£ããã±ã¢æ¹æ³ã解説
- è人æ§ã€ãïŒèæŒæ§è§åçïŒã®åçã§èŠãç¹åŸŽã»åå ã»æ²»çæ³
- éçã®çœãã¶ã€ã¶ã€ã»æ¯ç©Žã®ç°åžžã¯äœãåå ïŒçš®é¡ãšå¯ŸåŠæ³ã解説
ð åèæç®
- åœç«ææçç ç©¶æ – ãã«ãã¹ãŠã€ã«ã¹åçš®ïŒåçŽãã«ãã¹ãæ°Žçã»åž¯ç¶ç±ç¹ãEBãŠã€ã«ã¹ããµã€ãã¡ã¬ããŠã€ã«ã¹ãªã©ïŒã®ææçæ å ±ãææçµè·¯ãç«åŠããŒã¿ã蚺æã»æ²»çã«é¢ãã詳现æ å ±ã®åç §
- æ¥æ¬ç®èç§åŠäŒ – åçŽãã«ãã¹ã»åž¯ç¶ç±ç¹ã®èšºçã¬ã€ãã©ã€ã³ïŒæãŠã€ã«ã¹è¬ã®äœ¿çšåºæºã垯ç¶ç±ç¹åŸç¥çµçã®æ²»çæ¹éãåçºæå¶çæ³ã®é©å¿ãªã©ç®èçç¶ãäžå¿ãšããæ²»çæ³ã®æ ¹æ æ å ±ïŒã®åç §
- åçåŽåç – æ°Žçã¯ã¯ãã³å®ææ¥çš®åïŒ2014幎ïŒã垯ç¶ç±ç¹ã¯ã¯ãã³ã«é¢ããäºé²æ¥çš®å¶åºŠãæ§åšãã«ãã¹ãå«ãæ§ææç察çãåŠå©Šãžã®ææäºé²ã«é¢ããå ¬åŒã¬ã€ãã³ã¹ã®åç §
ç£ä¿®è å»åž«
髿¡ã康倪 å»åž«
ä¿æè³æ Œ
ãã©ãã©ã€èªå®å»
ç¥æŽ
- 2009å¹Žãæ±äº¬å€§åŠå»åŠéšå»åŠç§åæ¥
- 2009å¹Žãæ±äº¬éä¿¡ç é¢å€å
- 2012å¹Žãæ±äº¬èŠå¯ç é¢å€å
- 2012å¹Žãæ±äº¬å€§åŠå»åŠéšéå±ç é¢å€å
- 2019幎ãåœé¢æ²»ç責任è 就任
- ç®èè «çã»ç®èå€ç§é åã§15幎以äžã®èšåºçµéšãš30,000ä»¶è¶ ã®æè¡å®çžŸãæã¡ãå»åŠçæ ¹æ ã«åºã¥ãç£ä¿®ãæ åœ
- å°éåéïŒç®èè «çãç®èå€ç§ãç®èç§ã圢æå€ç§
- èšåºå®çžŸïŒ2024幎æç¹ïŒ ç®èè «çã»ç®èå€ç§æè¡ïŒ30,000件以äžãè èçæ²»çïŒ2,000件以äžãé ãã»èµ€ã顿²»çïŒ1,000件以äž
- ç£ä¿®é å ç®èè «çïŒã»ããã»ç²ç€ã»èèªè «ãªã©ïŒãç®èå€ç§æè¡ãç®èãããäžè¬å»çã³ã©ã ã«é¢ããå»çæ å ±
äœè€ãææš¹ å»åž«
ä¿æè³æ Œ
æ¥æ¬æŽåœ¢å€ç§åŠäŒæŽåœ¢å€ç§å°éå»
ç¥æŽ
- 2010幎ãçæ³¢å€§åŠå»åŠå°éåŠçŸ€å»åŠé¡åæ¥
- 2012å¹Žãæ±äº¬å€§åŠå»åŠéšä»å±ç é¢å€å
- 2012å¹Žãæ±äº¬éä¿¡ç é¢å€å
- 2013幎ãç¬ç«è¡æ¿æ³äººåŽåè å¥åº·å®å 𿩿§ 暪æµåŽçœç é¢å€å
- 2015幎ãåœç«ç ç©¶éçºæ³äºº åœç«åœéå»çç ç©¶ã»ã³ã¿ãŒç é¢å€åãçµãŠåœé¢å€å